Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binu Philip

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
WMJ : Official Publication of the State Medical Society of Wisconsin|June 26, 2003
Hyperemesis gravidarum: literature reviewBinu Philip
Clinical Imaging|July 4, 2006
Localizing hyperfunctioning parathyroid tissue: MRI or nuclear study or both?Shabana Saeed, Mike Yao, Binu Philip, et al.
Regulatory Toxicology and Pharmacology : RTP|July 20, 2025
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecificsSmitha Ps Pillai, Kaushik Datta, Petra Lutterbuese, et al.
Scientific Reports|June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver DiseaseDivya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
International Journal of Toxicology|May 13, 2023
Harihara M. Mehendale: A Life Dedicated to Mentoring and ResearchUdayan Apte, S Satheesh Anand, Murali Badanthadka, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
WMJ : Official Publication of the State Medical Society of Wisconsin|June 26, 2003
Hyperemesis gravidarum: literature reviewBinu Philip
Clinical Imaging|July 4, 2006
Localizing hyperfunctioning parathyroid tissue: MRI or nuclear study or both?Shabana Saeed, Mike Yao, Binu Philip, et al.
Regulatory Toxicology and Pharmacology : RTP|July 20, 2025
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecificsSmitha Ps Pillai, Kaushik Datta, Petra Lutterbuese, et al.
Scientific Reports|June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver DiseaseDivya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
International Journal of Toxicology|May 13, 2023
Harihara M. Mehendale: A Life Dedicated to Mentoring and ResearchUdayan Apte, S Satheesh Anand, Murali Badanthadka, et al.
Pageof 1